FDA NDC Directory · JSON-LD · Markdown
NDC 65219-039 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Labeler / Manufacturer | Fresenius Kabi USA, LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA213206 |
| Dosage form / route | INJECTION, SOLUTION · INTRAVENOUS |
| Active ingredients | VASOPRESSIN (20 [USP'U]/mL) |
| Marketing started | 20230526 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).